Chloroquine Market 2028 By Product, Application | The Insight Partners

Chloroquine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Injectables, Capsules, Tablets); Application (Malaria, Rheumatoid Arthritis, Others)

Report Code: TIPRE00021197 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Chloroquine is an aminoquinolone derivative originally developed in the 1940s for the treatment of malaria. It was chosen to treat malaria until the development of newer antimalarials such as artemisinin, pyrimethamine, and mefloquine. This drug is preferred for the treatment of different types of parasites and is administered through the oral route. These drugs are derived from quinoline molecules and have similar clinical indications and side effects.

MARKET DYNAMICS

Growing prevention and treatment of malaria, rheumatoid arthritis, and other autoimmune diseases along with the increasing prevalence of COVID-19 cases are the major factors for market growth. Moreover, due to COVID-19 pandemic, export and import of chloroquine across regions has been increased which is additionally impelling the market growth.

MARKET SCOPE

The "Chloroquine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Chloroquine market with detailed market segmentation by product and application. The Chloroquine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Chloroquine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The chloroquine market is segmented on the basis of product and application. Based on product, the market is segmented as injectables, capsules, and tablets. Based on application, the market is segmented as malaria, rheumatoid arthritis, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Chloroquine market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Chloroquine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Chloroquine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Chloroquine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Chloroquine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Chloroquine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Chloroquine in the global market. Below mentioned is the list of few companies engaged in the Chloroquine market.

The report also includes the profiles of key players in Chloroquine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and product and application s offered, financial information of last 3 years, key development in past five years.

  •   ABCAM PLC
  •   ADVANZ PHARMA CORP.
  •   BAYER AG
  •   CADILA HEALTHCARE LTD.
  •   IPCA LABORATORIES LTD.
  •   MYLAN NV
  •   NOVARTIS AG
  •   SANOFI
  •   SUN PHARMACEUTICAL INDUSTRIES LTD.
  •   TEVA PHARMACEUTICAL INDUSTRIES LTD.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chloroquine Market - By Product
1.3.2 Chloroquine Market - By Application
1.3.3 Chloroquine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHLOROQUINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHLOROQUINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHLOROQUINE MARKET - GLOBAL MARKET ANALYSIS
6.1. CHLOROQUINE - GLOBAL MARKET OVERVIEW
6.2. CHLOROQUINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CHLOROQUINE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INJECTABLES
7.3.1. Overview
7.3.2. Injectables Market Forecast and Analysis
7.4. CAPSULES
7.4.1. Overview
7.4.2. Capsules Market Forecast and Analysis
7.5. TABLETS
7.5.1. Overview
7.5.2. Tablets Market Forecast and Analysis
8. CHLOROQUINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MALARIA
8.3.1. Overview
8.3.2. Malaria Market Forecast and Analysis
8.4. RHEUMATOID ARTHRITIS
8.4.1. Overview
8.4.2. Rheumatoid Arthritis Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CHLOROQUINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Chloroquine Market Overview
9.1.2 North America Chloroquine Market Forecasts and Analysis
9.1.3 North America Chloroquine Market Forecasts and Analysis - By Product
9.1.4 North America Chloroquine Market Forecasts and Analysis - By Application
9.1.5 North America Chloroquine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Chloroquine Market
9.1.5.1.1 United States Chloroquine Market by Product
9.1.5.1.2 United States Chloroquine Market by Application
9.1.5.2 Canada Chloroquine Market
9.1.5.2.1 Canada Chloroquine Market by Product
9.1.5.2.2 Canada Chloroquine Market by Application
9.1.5.3 Mexico Chloroquine Market
9.1.5.3.1 Mexico Chloroquine Market by Product
9.1.5.3.2 Mexico Chloroquine Market by Application
9.2. EUROPE
9.2.1 Europe Chloroquine Market Overview
9.2.2 Europe Chloroquine Market Forecasts and Analysis
9.2.3 Europe Chloroquine Market Forecasts and Analysis - By Product
9.2.4 Europe Chloroquine Market Forecasts and Analysis - By Application
9.2.5 Europe Chloroquine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Chloroquine Market
9.2.5.1.1 Germany Chloroquine Market by Product
9.2.5.1.2 Germany Chloroquine Market by Application
9.2.5.2 France Chloroquine Market
9.2.5.2.1 France Chloroquine Market by Product
9.2.5.2.2 France Chloroquine Market by Application
9.2.5.3 Italy Chloroquine Market
9.2.5.3.1 Italy Chloroquine Market by Product
9.2.5.3.2 Italy Chloroquine Market by Application
9.2.5.4 Spain Chloroquine Market
9.2.5.4.1 Spain Chloroquine Market by Product
9.2.5.4.2 Spain Chloroquine Market by Application
9.2.5.5 United Kingdom Chloroquine Market
9.2.5.5.1 United Kingdom Chloroquine Market by Product
9.2.5.5.2 United Kingdom Chloroquine Market by Application
9.2.5.6 Rest of Europe Chloroquine Market
9.2.5.6.1 Rest of Europe Chloroquine Market by Product
9.2.5.6.2 Rest of Europe Chloroquine Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Chloroquine Market Overview
9.3.2 Asia-Pacific Chloroquine Market Forecasts and Analysis
9.3.3 Asia-Pacific Chloroquine Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Chloroquine Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Chloroquine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Chloroquine Market
9.3.5.1.1 Australia Chloroquine Market by Product
9.3.5.1.2 Australia Chloroquine Market by Application
9.3.5.2 China Chloroquine Market
9.3.5.2.1 China Chloroquine Market by Product
9.3.5.2.2 China Chloroquine Market by Application
9.3.5.3 India Chloroquine Market
9.3.5.3.1 India Chloroquine Market by Product
9.3.5.3.2 India Chloroquine Market by Application
9.3.5.4 Japan Chloroquine Market
9.3.5.4.1 Japan Chloroquine Market by Product
9.3.5.4.2 Japan Chloroquine Market by Application
9.3.5.5 South Korea Chloroquine Market
9.3.5.5.1 South Korea Chloroquine Market by Product
9.3.5.5.2 South Korea Chloroquine Market by Application
9.3.5.6 Rest of Asia-Pacific Chloroquine Market
9.3.5.6.1 Rest of Asia-Pacific Chloroquine Market by Product
9.3.5.6.2 Rest of Asia-Pacific Chloroquine Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Chloroquine Market Overview
9.4.2 Middle East and Africa Chloroquine Market Forecasts and Analysis
9.4.3 Middle East and Africa Chloroquine Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Chloroquine Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Chloroquine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Chloroquine Market
9.4.5.1.1 South Africa Chloroquine Market by Product
9.4.5.1.2 South Africa Chloroquine Market by Application
9.4.5.2 Saudi Arabia Chloroquine Market
9.4.5.2.1 Saudi Arabia Chloroquine Market by Product
9.4.5.2.2 Saudi Arabia Chloroquine Market by Application
9.4.5.3 U.A.E Chloroquine Market
9.4.5.3.1 U.A.E Chloroquine Market by Product
9.4.5.3.2 U.A.E Chloroquine Market by Application
9.4.5.4 Rest of Middle East and Africa Chloroquine Market
9.4.5.4.1 Rest of Middle East and Africa Chloroquine Market by Product
9.4.5.4.2 Rest of Middle East and Africa Chloroquine Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Chloroquine Market Overview
9.5.2 South and Central America Chloroquine Market Forecasts and Analysis
9.5.3 South and Central America Chloroquine Market Forecasts and Analysis - By Product
9.5.4 South and Central America Chloroquine Market Forecasts and Analysis - By Application
9.5.5 South and Central America Chloroquine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Chloroquine Market
9.5.5.1.1 Brazil Chloroquine Market by Product
9.5.5.1.2 Brazil Chloroquine Market by Application
9.5.5.2 Argentina Chloroquine Market
9.5.5.2.1 Argentina Chloroquine Market by Product
9.5.5.2.2 Argentina Chloroquine Market by Application
9.5.5.3 Rest of South and Central America Chloroquine Market
9.5.5.3.1 Rest of South and Central America Chloroquine Market by Product
9.5.5.3.2 Rest of South and Central America Chloroquine Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CHLOROQUINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CHLOROQUINE MARKET, KEY COMPANY PROFILES
12.1. ABCAM PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ADVANZ PHARMA CORP.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAYER AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CADILA HEALTHCARE LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. IPCA LABORATORIES LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYLAN NV
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. ABCAM PLC
2. ADVANZ PHARMA CORP.
3. BAYER AG
4. CADILA HEALTHCARE LTD.
5. IPCA LABORATORIES LTD.
6. MYLAN NV
7. NOVARTIS AG
8. SANOFI
9. SUN PHARMACEUTICAL INDUSTRIES LTD.
10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11. ALLIANCE PHARMACEUTICALS
12. MERCK
13. UNIPRIX
14. RISING PHARMACEUTICALS
15. FISHMAN CHEMICAL
TIPRE00021197
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount